Clinakos is proud to enable Patient Level Data for our large and small pharma clients

Clinakos is proud to enable Patient Level Data for our large and small pharma clients
September 6, 2022 Susan

Patient Level Data especially in oncology and rare diseases provides a unique opportunity for pharmaceutical franchise leaders and launch teams. Access to hard-to-find patient populations tying qualitative and quantitative research to real-time linked patient-level medical records including EMR, Lab, Pharmacy, and SODH is key to taking important decisions pre, peri, and post-launch. With patient adoption increasingly becoming important to launch success, Clinakos is proud to enable this key capability for our large and small pharma clients.